A5081118696- Behavioral Health and Interventions
- Mobile Health and mHealth Applications
- Multiple and Secondary Primary Cancers
- Digital Mental Health Interventions
- Migration, Health and Trauma
- Nutrition and Health in Aging
- Cancer Immunotherapy and Biomarkers
- Cancer Diagnosis and Treatment
- Racial and Ethnic Identity Research
- Renal cell carcinoma treatment
- Global Health Workforce Issues
Duke University
2021-2023
Digital health technologies, such as smartphones and wearable devices, promise to revolutionize disease prevention, detection, treatment. Recently, there has been a surge of digital studies where data are collected through bring-your-own-device (BYOD) approach, in which participants who already own specific technology may voluntarily sign up for the study provide their data. BYOD design accelerates collection from larger number than cohort design; this is possible because researchers not...
The Latinx Advocacy Team & Interdisciplinary Network for COVID-19 (LATIN-19) is a unique multi-sector coalition formed early in the pandemic to address multi-level health inequities faced by communities North Carolina. We utilized National Institute on Minority Health and Disparities (NIMHD) Research Framework conduct directed content analysis of 58 LATIN-19 meeting minutes from April 2020 through October 2021. Application NIMHD facilitated comprehensive assessment complex multidimensional...
<sec> <title>UNSTRUCTURED</title> Digital health technologies, such as smartphones and wearable devices, promise to revolutionize disease prevention, detection, treatment. Recently, there has been a surge of digital studies where data are collected through bring-your-own-device (BYOD) approach, in which participants who already own specific technology may voluntarily sign up for the study provide their data. BYOD design accelerates collection from larger number than cohort design; this is...
e16517 Background: Body composition (comp) is an increasingly recognized prognostic indicator in patients with cancer, but there are limited data regarding body comp measurements metastatic renal cell carcinoma (mRCC) treated immune checkpoint inhibitors. The goal of this study was to assess baseline and rates sarcopenia mRCC receiving ipilimumab + nivolumab (ipi/nivo) as first-line systemic therapy examine potential associations overall survival (OS). Methods: We conducted a retrospective...